2024 annual financial data
AgomAb Therapeutics 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -48,021,000 EUR and net income was -46,267,000 EUR.
Operating cash flow was Not available.
Get free AgomAb Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 EUR
- Operating income
- -48,021,000 EUR
- Net income
- -46,267,000 EUR
- Operating cash flow
- Not available